Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
about
Disrupted regulatory T cell homeostasis in inflammatory bowel diseasesTreating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseMucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative ColitisBacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies.Balance of CD8+ CD28+ / CD8+ CD28- T lymphocytes is vital for patients with ulcerative colitis.Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.Inhibition of Inflammatory Cytokines and Induction of Myeloid-Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis.Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.Inhibition of CXCL10 release by monomeric C3bi and C4b.
P2860
Q26774590-045E4B9D-A0E8-4E5E-A846-6480B1C6318BQ34008773-7587FB6D-DCFF-4736-A0A3-428DFE67DAF1Q34582547-1C59D6DF-C99F-42B1-BEB6-5A53AD16935DQ34604561-DAD76709-4B57-4F5B-B4A2-CECFE606EFB1Q34725846-9A55E2E6-3E6C-48D2-97ED-44C7D2FFA7BBQ34870365-71F4365C-0F80-4107-B3A6-87B62ED1B339Q34958550-30F5F8D2-D519-40AD-8402-917A1157A11AQ35846531-677DFBFE-8EA0-439C-9D88-0056E3972812Q37762230-DB75E15C-509E-4889-82EC-C346E498BFFDQ37809574-263481D2-D83E-4F2A-80A7-FCC2B0266CFFQ37993226-15E548AC-2DD4-4865-B860-0448A3C64D33Q38243723-E57BBE9B-108F-4477-A4FF-642A52DACDF0Q39424570-650AF8A5-398C-4DA6-8295-4E488ACD5CEDQ40197022-D3AB6BF7-B7C0-4397-BA42-BCF7CE0796C5Q40791556-FF1951A1-9CC8-47C1-B0B4-1692749E207BQ42343441-3596C58A-D594-4F10-8F37-68412298A7DFQ44111082-976EFCEC-B1D8-4FEC-80D2-EF335C417D98Q44433975-8163342E-EACB-4228-A693-272946E90562Q45114690-1378D505-EE50-43C3-AC05-E9D5F1EF0768Q47694487-5908A201-5DF2-4C4A-8C28-790C1255000BQ48296840-DE6077CA-56B9-41DB-A659-710CB8BEE416Q48301707-9E5E7104-55C6-4EA3-88EA-BA0B5A3581A9Q51727279-5F3CCC7A-2D03-4BA7-913B-11CD2E7B8377Q51765029-46A3D98E-0BDE-4D3A-B21F-676892724860Q53117222-3C2C4B14-A933-4BDD-A492-CEA5CD40F91EQ54336041-5CF17A52-1FFF-4382-855F-7B298DD86EDC
P2860
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@en
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@nl
type
label
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@en
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@nl
prefLabel
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@en
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@nl
P2093
P1476
Demonstration of low-regulator ...... monocyte adsorption apheresis.
@en
P2093
Hiroto Miwa
Katsuyuki Tozawa
Ken Fukunaga
Koji Kamikozuru
Kunio Ohnishi
Nobuyuki Hida
Tadashi Kosaka
Takayuki Matsumoto
Takeshi Kusaka
Yoko Yokoyama
P2888
P304
P356
10.1007/S10620-006-9560-Z
P577
2007-04-03T00:00:00Z